NSE filing, NSE: ASTEC. Summary written from the filing by ALFA Finder's alert engine.
Astec Lifesciences Ltd: key numbers
- Share price
- ₹599.50
- Market cap
- ₹1,336 Cr
- Revenue (annual)
- ₹448.1 Cr
- Net profit (annual)
- ₹-80.92 Cr
- P/E (TTM)
- -16.8×Sector 34.5×
- Promoter holding
- 71.96%+0.00% QoQ
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Astec Lifesciences Ltd
All →Astec Lifesciences Results Update
Astec LifeSciences released a press release on its Q2 and H1 FY27 results, approved October 26, 2026. Q2 FY27 losses widened year on year.
Astec Lifesciences Other Announcement
Astec LifeSciences filed a Reg 54 Nil Security Cover certificate for its listed unsecured NCDs, stating the security cover format is not applicable. This is routine compliance paperwork with no new money or business event.
Astec Lifesciences Q2 FY27 Results: Net Loss of ₹37.4 Cr, Loss Widens
Astec Lifesciences Ltd reported revenue from operations of ₹72 Cr (-2.3% YoY) and a net loss of ₹37.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹37.4 Cr
Astec Lifesciences Other Announcement
Astec Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Astec Lifesciences Debt & Borrowing: ₹25 Cr
Astec LifeSciences Limited has redeemed Commercial Papers amounting to ₹25 Crore. The payment was made on the maturity date, 13th October, 2026.
- Value
- ₹25.00 Cr
Astec Lifesciences Other Announcement
Astec Lifesciences filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026, confirming no rematerialization requests received.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.